Especially relevant in light of their torcetrapib disaster. They’re working on an OTC and spray version of Viagra. That’s just what we need. (via PharmaGossip)
How Pfizer plans to increase revenue
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
More in Uncategorized
Past Week
-
When grief hits all at once: a morning of heartbreak and love
-
How smartphones are stealing your focus—and what you can do about it
-
Internal Medicine 2025: inspiration at the annual meeting
-
Learning to trust your body again: Healing the hidden wounds of medical training
-
Why patients and doctors are ditching insurance for personalized care
-
Are quotas a solution to physician shortages?
-
Past 6 Months
-
How trade wars could destroy the U.S. health care system
-
How hospitals are quietly taking control of physicians
-
What happened to real care in health care?
-
The silent crisis hurting pain patients and their doctors
-
Doctors don’t need yoga, they need time to smoke
-
The unexpected truth behind these misdiagnosed medical cases
-
Recent Posts
-
The stigma surrounding diabetes harms those living with the condition. It’s time to finally stamp it out.
-
Clinical research is evolving. Patient involvement is no longer optional.
-
The anesthesia spectrum: Guiding patients through comfort options in oral surgery
-
Ditching insurance: How direct pay models enable personalized patient care [PODCAST]
-
Are quotas a solution to physician shortages?
-
Internal Medicine 2025: inspiration at the annual meeting
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
